18,262 Shares in Kenvue Inc. (NYSE:KVUE) Purchased by Horizon Kinetics Asset Management LLC

Horizon Kinetics Asset Management LLC purchased a new position in Kenvue Inc. (NYSE:KVUE) during the third quarter, HoldingsChannel reports. The fund purchased 18,262 shares of the company’s stock, valued at approximately $422,000.

Other large investors also recently added to or reduced their stakes in the company. Longfellow Investment Management Co. LLC grew its stake in Kenvue by 63.4% during the third quarter. Longfellow Investment Management Co. LLC now owns 29,523 shares of the company’s stock valued at $683,000 after acquiring an additional 11,459 shares in the last quarter. Whetstone Capital Advisors LLC bought a new stake in Kenvue in the third quarter worth $202,000. Independent Advisor Alliance raised its stake in Kenvue by 10.8% during the third quarter. Independent Advisor Alliance now owns 51,003 shares of the company’s stock valued at $1,180,000 after purchasing an additional 4,960 shares in the last quarter. Daiwa Securities Group Inc. lifted its position in Kenvue by 10.4% during the third quarter. Daiwa Securities Group Inc. now owns 253,455 shares of the company’s stock valued at $5,862,000 after purchasing an additional 23,936 shares during the last quarter. Finally, Larson Financial Group LLC grew its stake in shares of Kenvue by 81.8% in the 3rd quarter. Larson Financial Group LLC now owns 18,830 shares of the company’s stock worth $436,000 after buying an additional 8,473 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on KVUE shares. JPMorgan Chase & Co. increased their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Bank of America raised their price objective on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft boosted their target price on Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Piper Sandler raised their price target on Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, September 23rd. Finally, Jefferies Financial Group initiated coverage on shares of Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $22.64.

Kenvue Stock Up 0.7 %

Shares of NYSE KVUE opened at $24.25 on Tuesday. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.40. The firm has a market capitalization of $46.49 billion, a price-to-earnings ratio of 44.09, a PEG ratio of 2.19 and a beta of 1.36. The stock has a 50 day moving average price of $22.86 and a 200 day moving average price of $20.89. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.01. The business had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.31 EPS. Sell-side analysts expect that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.38%. The ex-dividend date is Wednesday, November 13th. Kenvue’s dividend payout ratio (DPR) is 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.